Quantum BioPharma Ltd.

CNSX:QNTM Stock Report

Market Cap: CA$64.9m

Quantum BioPharma Management

Management criteria checks 2/4

Quantum BioPharma's CEO is Zeeshan Saeed, appointed in Jun 2023, has a tenure of 2.33 years. total yearly compensation is $583.69K, comprised of 37.5% salary and 62.5% bonuses, including company stock and options. directly owns 3.28% of the company’s shares, worth CA$2.13M. The average tenure of the management team and the board of directors is 1.8 years and 4.1 years respectively.

Key information

Zeeshan Saeed

Chief executive officer

US$583.7k

Total compensation

CEO salary percentage37.46%
CEO tenure2.3yrs
CEO ownership3.3%
Management average tenure1.8yrs
Board average tenure4.1yrs

Recent management updates

Recent updates

Is Quantum BioPharma (CSE:QNTM) Using Too Much Debt?

Aug 09
Is Quantum BioPharma (CSE:QNTM) Using Too Much Debt?

We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate

Apr 13
We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate

We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate

Dec 17
We're Keeping An Eye On FSD Pharma's (CSE:HUGE) Cash Burn Rate

Here's Why We're Watching FSD Pharma's (CSE:HUGE) Cash Burn Situation

Aug 25
Here's Why We're Watching FSD Pharma's (CSE:HUGE) Cash Burn Situation

CEO Compensation Analysis

How has Zeeshan Saeed's remuneration changed compared to Quantum BioPharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

-US$27m

Mar 31 2025n/an/a

-US$21m

Dec 31 2024US$584kUS$219k

-US$14m

Sep 30 2024n/an/a

-US$10m

Jun 30 2024n/an/a

-US$7m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$600kUS$223k

-US$18m

Sep 30 2023n/an/a

-US$23m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$31m

Dec 31 2022US$774kUS$239k

-US$27m

Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$30m

Dec 31 2021US$1mUS$225k

-US$34m

Sep 30 2021n/an/a

-US$32m

Jun 30 2021n/an/a

-US$39m

Mar 31 2021n/an/a

-US$30m

Dec 31 2020US$899kUS$212k

-US$28m

Sep 30 2020n/an/a

-US$36m

Jun 30 2020n/an/a

-US$35m

Mar 31 2020n/an/a

-US$41m

Dec 31 2019US$2mUS$249k

-US$34m

Sep 30 2019n/an/a

-US$38m

Jun 30 2019n/an/a

-US$25m

Mar 31 2019n/an/a

-US$16m

Dec 31 2018US$503kUS$183k

-US$17m

Compensation vs Market: Zeeshan's total compensation ($USD583.69K) is above average for companies of similar size in the Canadian market ($USD164.23K).

Compensation vs Earnings: Zeeshan's compensation has been consistent with company performance over the past year.

CEO

Zeeshan Saeed (55 yo)

2.3yrs
Tenure
US$583,685
Compensation

Mr. Zeeshan Saeed is Independent Co-Chairman of Unbuzzd Wellness Inc. from August 01, 2023. Mr. Saeed is the CEO, Founder and Executive Co-Chair of the board at Quantum BioPharma. He joined the company whe...

Leadership Team

NamePositionTenureCompensationOwnership
Zeeshan Saeed
Co-Founder2.3yrsUS$583.69k3.28%
CA$ 2.1m
Anthony Durkacz
Co-Founder & Executive Non-Independent Co-Chairman7.3yrsUS$583.69k0.81%
CA$ 522.8k
Donal Carroll
Chief Financial Officer1.2yrsUS$583.69k2.38%
CA$ 1.5m
Nathan Coyle
Controller1.2yrsUS$104.92k0.0010%
CA$ 648.9
Lakshmi Kotra
CEO of Lucid & Director4.1yrsUS$59.79k0.77%
CA$ 502.7k
Andrzej Chruscinski
Vice President of Clinical & Scientific Affairsno dataUS$178.21kno data
Ashwini Joshi
Director of Pharmaceutical Developmentno dataUS$104.56kno data
Jason Sawyer
Head of Finance & Mergers and Acquisitions1.2yrsno datano data
Maryann Adesso
Corporate Secretaryno datano datano data
Randell Mack
President of FSD BioSciences4.6yrsno datano data
Kevin Cassidy
Vice President of Quality-Lucidno dataUS$144.82kno data
1.8yrs
Average Tenure
48.5yo
Average Age

Experienced Management: QNTM's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Zeeshan Saeed
Co-Founder4.4yrsUS$583.69k3.28%
CA$ 2.1m
Anthony Durkacz
Co-Founder & Executive Non-Independent Co-Chairman7.3yrsUS$583.69k0.81%
CA$ 522.8k
Lakshmi Kotra
CEO of Lucid & Director2.9yrsUS$59.79k0.77%
CA$ 502.7k
Daniele Piomelli
Member of Research & Clinical Advisory Board3.8yrsno datano data
Eleanor Fish
Member of Research & Clinical Advisory Board3.9yrsno datano data
Hance Clarke
Member of Research & Clinical Advisory Board4.1yrsno datano data
Eric Hoskins
Independent Director2.4yrsUS$117.51kno data
Adnan Bashir
Independent Director4.3yrsUS$43.73k0.0038%
CA$ 2.4k
Peter Stys
Member of Research & Clinical Advisory Board4.1yrsno datano data
Shannon Dunn
Member of Research & Clinical Advisory Board4.1yrsno datano data
Albert Wong
Member of Research & Clinical Advisory Board4.1yrsno datano data
Joga Gobburu
Member of Regulatory Advisory Board3.9yrsno datano data
4.1yrs
Average Tenure
55yo
Average Age

Experienced Board: QNTM's board of directors are considered experienced (4.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/31 04:13
End of Day Share Price 2025/10/31 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Quantum BioPharma Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaBrookline Capital Markets
Karen SterlingKingswood Capital